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The aim of this study was to determine whether the reduction of seizures in patients with
intractable epilepsy after self-regulation of slow cortical potentials (SCPs) was maintained
almost 10 years after the end of treatment. Originally, 41 patients received training with
SCP-neurofeedback. A control group of 12 patients received respiratory feedback while
another group of 11 patients had their anticonvulsant medications reviewed. Nineteen
patients in the experimental group participated at least in parts of the long-term follow-up,
but only two patients from each control group agreed to do so. The follow-up participants
completed the same seizure diaries as in the original study. Patients of the experimental
group also took part in three SCP-training sessions at the follow-up evaluation. Due to the
small sample size, the results of participants in the control groups were not considered in
the analysis. A significant decrease in seizure frequency was found about 10 years after the
end of SCP treatment.The clinical significance of this result is considered medium to high.
All patients were still able to self-regulate their SCPs during the feedback condition. This
success was achieved without booster sessions. This is the longest follow-up evaluation
of the outcome of a psychophysiological treatment in patients with epilepsy ever reported.
Reduced seizure frequency may be the result of patients continued ability to self-regulate
their SCPs. Given such a long follow-up period, the possible impact of confounding variables
should be taken into account. The small number of patients participating in this follow-up
evaluation diminishes the ability to make causal inferences. However, the consistency and
duration of improvement for patients who received SCP-feedback training suggests that
such treatment may be considered as a treatment for patients with intractable epilepsy
and as an adjunct to conventional therapies.
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INTRODUCTION
About one-third of patients with epilepsy do not respond to anti-
epileptic drugs (AED). New AED and surgery are the standard
treatment for those patients but still a considerable percentage of
patients are left being drug resistant. The majority of these patients
suffer from focal seizures. Especially for these kind of seizures
feedback of brain activity (EEG-feedback, mostly called neuro-
feedback) has been developed and evaluated since last decades of
the last century independently by two different research groups.
A decrease of seizures after enhancement of the sensory motor
rhythm in patients with poorly controlled epilepsies was reported
in 1972 for the first time (Sterman and Friar, 1972). This treat-
ment was motivated by earlier animal studies. Here, it was shown
that cats being trained to enhance their SMR were more resistant
to the exposition to a rocket fuel called monomethylhydrazine.
Compared to cats that had not undergone SMR-training these cats
showed elevated seizure thresholds and longer latencies (Sterman
et al., 1969; Sterman, 1976). It was concluded that SMR-training
decreased seizure susceptibility. Protocols for increasing SMR-
activity and in some studies decreasing slow rhythms (delta and
theta) of EEG have been used in the following years for research
and practice mainly in the United States (for a review see Tan
et al., 2009). In parallel to this development, Rockstroh et al.
(1993) were able to reduce seizures after feedback of slow cortical
potentials (SCPs).
Slow cortical potentials are very slow phenomena of the EEG
with a frequency near 0.01 Hz; their duration is up to several sec-
onds. Negative shifts reflect low excitation thresholds that precede
epileptic seizures (Ikeda et al., 1996). As the above mentioned trial
by Rockstroh et al. (1993) was not controlled Kotchoubey et al.
(2001) wanted to replicate the results in a controlled study. Patients
being diagnosed as having focal epilepsies were referred to the
study centers (University of Tuebingen, Neurological Clinic Weis-
senau, and Center for Epilepsies (Epilepsiezentrum Kehl-Kork) by
their neurologists or general practitioners. The study centers did
the additional screening with regards to the following selection
criteria: partial epilepsy being diagnosed at least 2 years ago; no
reduction of seizures after 2 years of pharmacological treatment
(i.e., the epilepsy was declared as pharmaco-resistant); age between
14 and 50 years; IQ above 80; no change in medication beginning
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from baseline until 1 year after the end of treatment (SCP and
RESP groups); no psychogenic seizures, no psychiatric disease
according to DSM IV (American Psychiatric Association, 1994).
To maximize effects of expectancy patients were allowed to
choose 1 out of 3 treatments: while 41 patients received feed-
back of SCPs, 11 were trained to self-regulate breathing rate
and amount of exhaled CO2 (respiratory feedback – RESP) and
another group of 12 patients had their medications reviewed
(MED). All groups were provided with the same amount of psy-
chosocial treatment: while the feedback groups (SCP and RESP)
were trained to apply the self-regulation skills in real-life situations,
the MED group received sessions of art therapy, occupational
therapy, physiotherapy, and training of social competence.
It was shown that patients acquired the SCP self-regulation skill,
which even improved during the follow-up period (Kotchoubey
et al., 1997). A 1 year follow-up showed that seizure frequency
decreased significantly in the SCP and MED groups, only
(Kotchoubey et al., 2001). Psychological variables (depression,
locus of control) improved in all treatment groups (Strehl et al.,
2005) but IQ changed in the SCP group only (Strehl et al., 2011).
About 9 years after the end of treatment, we wanted to know
whether the seizure control was maintained in the SCP group and
to compare their results with the results of the other two groups.
The study was approved by the local Ethics Committee of the Fac-




All patients that had finished the 12 months follow-up were asked
whether they would like to take part. A total of 23 responded.
Table 1 gives an overview of patients in the treatment groups.
Due to the small number of RESP and MED patients will-
ing to take part in the follow-up-study only SCP patients were
included. As depicted in Table 1, these 19 subjects account for
39% of those patients who joined the study and 47% of those who
took part in the 1 year follow-up evaluation. From these 19 sub-
jects, 16 submitted seizure data and took part in the SCP sessions.
The characteristics of these participants are described in Table 2.
TREATMENT
As described in detail elsewhere (Kotchoubey et al., 2001) patients
received treatment in either of three groups:
MED: these patients had been treated in the Epilepsiezentrum
Kehl-Kork. During a stay of 6–8 weeks their medication therapy
was reviewed and changed. In addition, they took part in daily
sessions of different kinds of therapy aiming at improving their
psychosocial well-being.
RESP: these patients had been treated in the Center of Psychiatry
Weissenau, Department of Neurology and Psychiatry with 35 ses-
sions’ respiration feedback according to Fried et al. (1984). The
task was to decrease the respiration rate and to increase the end-
tidal carbon dioxide (ETCO2) by 5%. The aim of this treatment
is to avoid hyperventilation, which may elicit seizures.
SCP: these patients had been treated in all study centers
(University of Tuebingen, Neurological Clinic Weissenau, and
Table 1 | Participants in the original study and the follow-up
evaluations.
Participants SCP MED RESP
Original study 41 12 11
1 year Follow-up 34 11 7
Willing to take part in 8 years FU 19 2 2
Percentage, compared with the beginning of
treatment
46 17 18
Percentage, compared with 1 year FU 56 18 29
Completed 8 years FU 16
Percentage, compared with the beginning of
treatment
39
Percentage, compared with 1 year FU 47
Table 2 | Characteristics of long-term follow-up participants.
Sex 7 Female; 9 male
Age at long-term follow-up Mean 46; range 31–59 years
Education Mean 11 years (SD 2)
First seizure (age) Birth – 43 years
Seizure type (number of patients) 2 Simple focal
6 Simple and complex focal
2 Simple, complex, and
secondary generalized
6 Complex focal
Seizures/week (baseline) Mean 3.49, range 0.08–25.58
Number of anti-epileptic drugs (AED)
(baseline)
Mean 2.32, range 1–4
Number of anti-epileptic drugs (AED)
(long-term follow-up)
Mean 2.12, range 1–4
Surgery after 1 year FU (number of
patients)
3
Epilepsiezentrum Kehl-Kork). They received 35 sessions feed-
back of SCPs. As in the RESP group, the treatment was divided
into two phases of 20 and 15 sessions. In addition to the feedback
sessions, patients of both groups received daily sessions aiming at
transferring the self-regulation skill from the lab into everyday life
and improving psychosocial well-being. Patients are instructed to
identify seizure prone situations and to use the skill in order
to inhibit excessive cortical excitation that might lead into a
seizure.
Slow cortical potentials were recorded at Cz, referenced against
two electrodes at the mastoids. A session consisted of 145 trials of
8 s duration. Patients were either prompted to produce negative or
positive shifts. In less than half of the trials no feedback was given.
These transfer trials were introduced to prepare patients to use the
skill in their daily life where external feedback is not available.
The timeline of the assessments and treatment is depicted in
Figure 1.
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FIGURE 1 |Timeline of assessments of seizure frequency, treatment, and follow-up evaluations. *Fragebogen zur Kontrolle von Anfällen (COE, control of
epileptic seizures questionnaire) by Trevorrow T and Strehl U, unpublished.
ASSESSMENT
During the main study seizure frequency, several psychological
measures and performance of self-regulation (SCP and RESP
groups) were assessed as independent variables. Patients were edu-
cated how to fill in the seizure diary by personal as well as by written
instructions.
In the long-term follow-up reported here self-regulation of
SCP and the assessment of seizure frequency was the main focus.
According to the timeline (see Figure 1) seizure frequency was
assessed as follows:
T1: baseline before treatment: during the 12 week baseline assess-
ment patients sent the daily diaries weekly by surface mail to their
study center.
T2: after the end of treatment: during the 52 weeks follow-up
period, patients used the same forms that had to be sent to the
centers every month.
T3: patients who wanted to take part in the long-term FU
reported the mean seizure frequency per month during the last
year. This report was based on whatever the patients had used
to recall seizure frequency: specific diaries or marks in their
calendars.
T4: 12 weeks baseline similar to the baselines at T1 and T2.
Patients had to send their weekly diaries every month to the
center (Tuebingen). If they were not sent in time, patients were
reminded by phone or e-mail.
T5: as a preparation for the follow-up meeting patients were asked
to return a questionnaire about their perceived control over their
seizures. One of the questions referred to the number of monthly
seizures patients had experienced during the last half-year.
T6: patients took part in three sessions SCP-feedback over two
consecutive days. While during the main study a Neurofax
amplifier (Nihon Kohden) was used, for this long-term eval-
uation a special equipment produced for neurofeedback was
available (Neuro Prax® from neuroConn GmbH, Germany;
http://www.neuroconn.de/startseite_en/) that had been devel-
oped according to our requirements. The main difference
between the old and new system is in their appearance. The new
system is colored and the prompt for the task is a triangle pointing
to the top (negativation) or bottom (positivation) of the screen.
As cursor for the feedback subjects have the choice between dif-
ferent objects (fish, bird, airplane, boat, and more). The technical
details of recording, amplifying, artifact correction, and feedback
parameter were comparable to the equipment used in the orig-
inal study. An additional feature of artifact correction was the
eye movement calibration before the start of the recording that
allowed online control of artifacts and feedback of these artifacts
to the patient. Trials where such an artifact was detected were
declared as invalid and were repeated. Each session consisted of
140 trials divided into 5 runs. The succession of runs, their condi-
tions (feedback and transfer) and number of tasks (negativation
and positivation) is depicted in Table 3.
The duration of each trial was 8 s. With the appearance of the
triangle the trial started and the value taken during the 2 s baseline
immediately preceding the trial was set to 0. If the patient suc-
ceeded in shifting the potential as required during last third of the
trial the picture of a sun appeared on the screen (see Figure 2).
DATA ANALYSIS
Patients
As depicted in Table 2, three of the 16 patients who took part in the
long-term follow-up had undergone surgery due to their epilepsy
in the years after the 1 year follow-up. Therefore, their data are
not included in the group analysis but if possible will be reported
separately.
In order to detect a possible bias due to the self-selection of
patients taking part in the long-term follow-up,we compared them
with those who refused to participate using the following variables:
age, education, age of first seizure, duration of illness, number of
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AED, number of seizures at T1 and T2, change of seizure rate, pre
and post values of IQ. While the variables of seizure frequency
were tested with Mann–Whitney U -test, all other variables were
compared with t -tests for independent samples.
SCP sessions
Data of all three sessions were analyzed with the “Analyzer” soft-
ware offered by the Neuro Prax®. In preprocessing of data a
low pass filter of 4 Hz was used, all trials with eye artifacts as
well as trials with amplitudes >200µV were discarded. For the
remaining trials mean values of amplitudes during 5–8 s were com-
puted separately for negativity and positivity tasks during feedback
Table 3 | Composition of tasks and conditions during one session.
Run number 1 2 3 4 5
Condition Feedback Transfer Feedback Transfer Feedback
Trials 40 20 30 20 30
Positivation tasks (%) 60 60 60 60 60
and transfer trials. It was analyzed whether the amplitudes in
the positivity tasks and the negativity tasks differed significantly
from each other and for both conditions (feedback and transfer).
An additional repeated measures analysis of variance (ANOVA)
with the factors: Task (negativity/positivity), Session (three ses-
sions), and Condition (feedback/transfer) was conducted. Data
were computed only for patients without surgery.
Seizures
Because seizure frequencies have a notorious asymmetric distribu-
tion, using parametric methods for their analysis requires caution.
Therefore, several normalizing transformations were tested, and
decimal logarithms proved to yield the best approximation to nor-
mality. After this transformation, one patient had to be excluded
from the analysis as outlier. A second participant was excluded
because his diaries at T4 were not valid. After this, a repeated
measures ANOVA with all assessment points was performed with
the remaining 11 patients without surgery. In addition, the trends
were tested for significance.
Due to the different instruments in assessing seizure frequency
all data were analyzed in paired comparison (Wilcoxon-Test, not
FIGURE 2 | Discontinuous feedback. Monitor screens during tasks
(negativation and positivation) and conditions (feedback and transfer). If the
cursor (in this example a “fish”) is moved in the direction as prompted (up,
negativation; down, positivation) a “sun” is shown at the end of the trial. In
the case of no success, the screen is empty as shown in the bottom line.
Screen shots with friendly permission by neuroConn, Ilmenau, Germany.
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corrected). Finally, a pre (baseline before treatment) versus post




There was no difference between participants and those patients
who were not willing to take part in any of the variables tested.
SELF-REGULATION OF SCP
As indicated by a significant main effect of task [F(1,10)= 5.46,
p= 0.042, η2= 0.35], patients successfully differentiated between
the positivity and negativity tasks. The non-significant task by con-
dition interaction (F < 1) shows that the correct trend to positive
SCP with the positivity task and negative SCP with the negativity
task was identical for both feedback and transfer conditions. How-
ever, when the data for each condition were analyzed separately,
the effect of task was significant only in the feedback condition
[F(1,10)= 5.73, p= 0.038,η2= 0.36], but not in the transfer con-
dition [F(1,10)= 2.48,p= 0.15]. Figure 3 depicts the performance
in detail for both patients without surgery and with surgery. The
interaction between sessions and tasks did not reach significance
although for positivity tasks the best results were obtained in ses-
sion 2. In the negativity task, the amplitudes increased from session
to session during feedback but did not reach significance.
SEIZURES
The mean seizure frequency at baseline (T1) in the 11 patients who
had not undergone surgery was 3.49/week, median 2.46/week. At
the different assessment points after treatment, from T2 to T5, the
means were between 2.1 and 0.8/week, medians between 1.13 and
0.52/week. As seizures at T1 and T4 were assessed with exactly the
same instruments, percentages of seizure decrease were calculated
between these two measurement points for each patient, if applic-
able. Seizure frequency decreased in 8 of 11 patients, in 6 of them
the decrease was more than 50%.
One of the 11 patients without surgery who was included in the
analysis was seizure free, and 1 of the 3 patients with surgery was
seizure free, too.
The ANOVA for all patients without surgery yielded a statis-
tically significant effect of Time with F(4,40)= 4.03, p= 0.025
(corrected with Greenhouse-Geisser Epsilon). The effect size (η2)
was 0.287. The linear trend was significant with F(1,10)= 8.87,
p= 0.014, and η2= 0.47.
Pairwise comparisons revealed significant differences (p< 0.05)
between T1 and each of the following assessment points, with the
effect sizes (Cohen’s d) between 0.45 (T2–T3 difference) and 0.51
(T1–T4 difference). None of the differences between the later time
points (from T3 to T5) attained or even approached significance.
The three patients with surgery had at baseline seizure fre-
quencies of 1.42, 0.91, and 0.54/week, which is below the average
frequency for the non-operated patients (3.89/week). In the first
of them, the frequency decreased to 0.27/week after surgery, while
it did not substantially change in the other two.
DISCUSSION
Monitoring and follow-up of anti-epileptic treatment is an
important issue of the patient–therapist journey (Groenewe-
gen et al., 2014). These authors concluded their multinational
patient–physician survey with the statement that successful treat-
ment depends on communication over the long-term. For the
group of patients treated with SCPs feedback in the main study
(Kotchoubey et al., 2001) who improved although diagnosed as
“intractable” the long-term outcome is of special interest. Reduc-
tion of seizures after neurofeedback in 74% of patients has been
already reported in a meta-analysis (Tan et al., 2009) but long-term
FIGURE 3 | Self-regulation of SCP. -x-, mean value and confidence interval
for all sessions of patients without surgery; -o-, mean value and confidence
interval for all sessions of patients with surgery. FB−, negativity tasks with
feedback; FB+, Positivity tasks with feedback. FB diff, difference between
shifts during negativity and positivity tasks with feedback. TF+, positivity
tasks without feedback (transfer); TF−, negativity tasks without feedback
(transfer); TF diff, difference between shifts during negativity and positivity
tasks without feedback (transfer).
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data are not available, except the 1 year follow-up of the study
reported from our group before (Kotchoubey et al., 2001). A long-
term outcome after a period of 9 years after the end of treatment
presented in this paper was assessed for the first time. While the
original study compared SCPs feedback with two different treat-
ments (review of medication regime and respiratory feedback)
only patients of the SCP group were willing to take part in a num-
ber sufficient for analysis. One-third of those patients who started
the treatment (and 47% of those who completed the 1 year follow-
up) again completed seizure diaries and took part in three sessions
of neurofeedback. A statistically significant continuous decrease of
seizures from the first baseline to the last estimation of seizure fre-
quency was observed. The effect sizes were large for the linear
trend and medium for the general linear model. Pairwise compar-
isons revealed that the decrease did not depend on the assessment
instrument (specific diaries to be sent to the lab; regular diaries
as usual, estimation in the COE questionnaire). Participants were
still able to self-regulate their SCPs as shown by a significant differ-
entiation between negativity and positivity tasks in the feedback
condition. Compared with the self-regulation skills during both
feedback and transfer demonstrated 6 month after the end of treat-
ment (Kotchoubey et al., 1997) the achievement 10 years later were
more moderate,which might partially attributed to the small num-
ber of participants. Taking into account the long period without
any booster sessions in between it appears surprising that the self-
regulation skill was still existent at all. We therefore may assume
that participants have successfully acquired a self-regulation skill,
which is available for retrieval in their implicit memory. The
longest follow-up that showed sustained SCP self-regulation skill
reported so far was 2 years in a neurofeedback-study in chil-
dren with Attention-Deficit-/Hyperactivity-Disorder (Gani et al.,
2008).
It would be of interest to analyze a possible correlation between
self-regulation performance and reduction of seizures. In an earlier
paper with 18 patients at the 6 month follow-up of the main study,
it was shown that patients with larger amplitudes of positivity and
especially during transfer trials experienced greater improvements
(Kotchoubey et al., 1997). A power analysis as regards to the small
number of participants in the long-term follow-up revealed that a
correlation coefficient of 0.6 would be needed in order to obtain a
significant result, which is not realistic to expect.
A comparison with the outcome of other treatments is hardly
possible. Long-term follow-up-studies that exceed 3–5 years are
rather rare. The longest follow-up we retrieved was 12 years done
by Tanriverdi et al. (2008) with patients after temporal lobe surgery
(Kunieda et al., 2013), 10 years after resective surgery (Stigsdotter-
Broman et al., 2014), and after callosotomy (Ardesch et al., 2007)
and 6 years after vagus nerve stimulation (VNS) (Tang et al., 2014).
Besides these interventions medication treatments are mostly fol-
lowed up for a maximum of 3–5 years. For psychobehavioral
treatments, long-term results are missing and the sustainabil-
ity of outcomes are uncertain (Shorvon and Goodridge, 2013).
Another difference to our study concerns the method of record-
ing seizure frequency. While we used prospective measures, which
were similar before and after treatment, many follow-up stud-
ies assessed seizure frequency by phone calls. It is questionable
whether this method is adequate, and if yes, whether those results
are comparable to ours. Finally, a comparison does not make much
sense because the patients in our study had refractory epilepsy, i.e.,
with no response to medication treatment and not being willing
or eligible for surgery. However, a comparison with the results of
VNS for medically refractory epilepsy seems to be more justified.
Ardesch et al. (2007) report seizure reduction increasing from 14%
after the first year to 50% after 6 years follow-up in a group of 19
patients (Tang et al., 2014). Contrary to other studies (e.g., Sperner
et al., 2005), which state that the early response predicts the long-
term outcome, in the VNS study, the improvements were small at
the beginning, increasing in the following years (Tang et al., 2014).
A similar development was observed in our study, but percentages
increased from 40 to 76%. According to a pilot study (Brodie,2013)
both VNS and SCP treatment might have a common mechanism
of effect, namely, the increase of excitation thresholds of corti-
cal neurons. An advantage of SCP-feedback compared to VNS is
not only the bigger decrease of seizures but also the absence of side
effects. Taking these results into consideration, it may be suggested
that SCP-feedback might be recommended as a novel approach,
which may meet the demands in treating patients with refractory
epilepsies (Hoppe et al., 2007).
Of course several limitations have to be acknowledged. First
of all, we were not able to compare with the control groups of
the original study as not enough patients from these groups were
willing to take part. One reason why only 17% (MED) and 18%
(RESP) patients responded could be that these patients had been
contacted before only by their study centers but not by the Uni-
versity of Tuebingen, now asking for their participation. Due to
constraints set up by the Ethics Committee, we were not allowed to
ask for reasons for no participation. Therefore, we cannot exactly
estimate the impact of these missing data on the results but it
is worth noticing that we did not find any difference in demo-
graphic and seizure characteristic between those who took part
and those who did not. Another limitation may concern the relia-
bility of the number of seizures as indicated by the patients. Several
authors who tried to obtain greater accuracy by ambulatory or in-
patient EEG assessment report that around 50% of seizures are
not declared (e.g., Kerling et al., 2006; Tanriverdi et al., 2008). This
problem is not unique to our study. Instead, it has to be taken into
account by any study (and any report in the doctor’s office) that
relies on patients’ statements. It is all the more important that we
used identical forms to record seizures in three of five assessment
points. Finally, the impact of confounding variables throughout
all the years that passed by since the end of the treatment has to
be considered (which is also true for other studies). Due to the
small number of patients we were not able to assess these variables
on a systematic basis. We do not know what impact possible posi-
tive changes in the quality of life, education, occupation, or family
status might have had on the seizures. Neither do we know what
impact the reduction of seizures can have on the aforementioned
variables. An exact control of the effect of everyday life would
require a huge number of patients at the beginning of a study. If
this would be a condition sine qua non-the majority of long-term
studies done so far are done in vain.
To summarize the main limitation of this study is the small
number of patients that do not allow us to draw causal conclusions.
Notwithstanding this small sample size, statistically significant
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long-term reduction of seizures and sustained self-regulation of
SCPs were observed. It has to be noted that this success was
achieved without booster sessions. Future research should not
only try to replicate these promising results but also include SCP-
feedback treatment as an option in the treatment of patients with
(intractable) epilepsies.
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